Notes in Bone metastases

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	MSK \| Bone mets \| 6.3 \| Surgery \| Epidural spinal cord compression
Published	02/18/2024	MSK \| Bone mets \| 1.1 \| Incidence, distribution, morphology, complications
Published	02/18/2024	MSK \| Bone mets \| 1.2 \| Most common primary tumours
Published	02/18/2024	MSK \| Bone mets \| 1.3 \| Mechanisms of pain
Published	02/18/2024	MSK \| Bone mets \| 1.4 \| Pathophysiology of bone metastases
Published	02/18/2024	MSK \| Bone mets \| 1.5 \| Route of spread
Published	02/18/2024	MSK \| Bone mets \| 1.6 \| Classification
Published	02/18/2024	MSK \| Bone mets \| 1.7 \| DDx
Published	02/18/2024	MSK \| Bone mets \| 1.8 \| Specific routes of spread
Published	02/18/2024	MSK \| Bone mets \| 2 \| Workup
Published	02/18/2024	MSK \| Bone mets \| 3.1 \| Management \| General principles
Published	02/18/2024	MSK \| Bone mets \| 3.2 \| Management \| Overview
Published	02/18/2024	MSK \| Bone mets \| 4.1 \| Pharmacologic \| Analagesia
Published	02/18/2024	MSK \| Bone mets \| 4.2 \| Pharmacologic \| RANKL inhibitor
Published	02/18/2024	MSK \| Bone mets \| 4.3.1 \| Pharmacologic \| Bisphosphanate
Published	02/18/2024	MSK \| Bone mets \| 4.4 \| Pharmacologic \| Hormone therapy
Published	02/18/2024	MSK \| Bone mets \| 4.5 \| Chemotherapy
Published	02/18/2024	MSK \| Bone mets \| 5 \| Supportive care
Published	02/18/2024	MSK \| Bone mets \| 6.1 \| Surgery \| Impending pathologic fracture
Published	02/18/2024	MSK \| Bone mets \| 6.2 \| Surgery \| Spinal instability
Published	02/18/2024	MSK \| Bone mets \| 7.1 \| RT \| Overview and summary of ASTRO 2011 guidelines
Published	02/18/2024	MSK \| Bone mets \| 7.2 \| RT \| Optimal fractionation - single vs. multiple
Published	02/18/2024	MSK \| Bone mets \| 7.3 \| RT \| Single fraction: optimal dose
Published	02/18/2024	MSK \| Bone mets \| 7.4 \| RT \| Optimal fractionation: Neuropathic pain
Published	02/18/2024	MSK \| Bone mets \| 7.5 \| RT \| Hemibody RT
Published	02/18/2024	MSK \| Bone mets \| 7.6 \| RT \| Re-irradiation
Published	02/18/2024	MSK \| Bone mets \| 7.7.1 \| RT \| SBRT
Published	02/18/2024	MSK \| Bone mets \| 8.1 \| Radioisotopes \| Rationale, efficacy, indications, contraindications, pre-Rx assessment,  S/E, post-Rx instructions
Published	02/18/2024	MSK \| Bone mets \| 8.2 \| Radioisotopes \| Half lives
Published	02/18/2024	MSK \| Bone mets \| 8.3 \| Radioisotopes \| Physical considerations
Published	02/18/2024	MSK \| Bone mets \| 8.4 \| Radioisotopes \| Strontium 89
Published	02/18/2024	MSK \| Bone mets \| 8.5 \| Radioisotopes \| Samarium 153-EDTMP
Published	02/18/2024	MSK \| Bone mets \| 8.6 \| Radioisotopes \| Radium 223
Published	02/18/2024	MSK \| Bone mets \| 4.3.2 \| Pharmacologic \| Bisphosphanate \| Breast cancer
Published	02/18/2024	MSK \| Bone mets \| 4.3.3 \| Pharmacologic \| Bisphosphanate \| Prostate cancer
Published	02/18/2024	MSK \| Bone mets \| 4.3.4 \| Pharmacologic \| Bisphosphanate \| Multiple myeloma
Published	02/18/2024	MSK \| Bone mets \| 7.7.2 \| RT \| SBRT \| Treatment technique \| CTV delineation
Published	02/18/2024	MSK \| Bone mets \| 7.7.3 \| RT \| SBRT \| RT technique \| Spinal cord contouring and dose constraint
Status	Last Update	Fields